|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||24.98 mL||124.91 mL||249.81 mL|
|0.5 mM||5 mL||24.98 mL||49.96 mL|
|1 mM||2.5 mL||12.49 mL||24.98 mL|
|5 mM||0.5 mL||2.5 mL||5 mL|
*The above data is based on the productmolecular weight 400.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Antagonist|
|Storage||at -20°C 3 years Powder|
A-1155463 is a highly potent and selective BCL-XL inhibitor, A-1155463 shows picomolar binding affinity to BCL-XL (Ki = 1000-fold weaker bin…
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32μM, 0.48μM and 0.18μM.
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer mediated through a novel pathway…
Bcl-2 Inhibitor contains a mixture of two tautomers. A potent, cell-permeable, Bcl-2 inhibitor competes with Bak BH3 peptide for binding to …
AT101, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32 μM, 0.48 μM and 0.18 μM; does not…